Verena Schöwel, MD

Dr. med. Verena SchöwelPhysician and postdoctoral fellow

This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49 30 450 540 514 (Office)
Phone: +49 30 450 540 528 (Outpatient clinic)
Fax:     +49 30 450 540 907

Projects and Fields of responsibilty

Physician in the outpatient clinic for muscle disorders
KAP-Project: Peptide mediated retargeting of dysferlin: Generation of an animal model
Myology: Membrane repair in human skeletal myotubes
KFO192 – Project 6: The effect of heterozygous myostatin knock-down in dysferlin deficient mice
MyoGrad – E-learning team

Scientific background

Medical School, University of Rostock and Heidelberg, Germany, Rotation at University van Stellbosch, South Africa

Graduation "Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir". Department of Clinical Pharmacology, University of Heidelberg, Germany

Ongoing residency, Research fellow and Physician in the Outpatient Clinic for Muscular Disorders, Muscle Research Unit, Experimental and Clinical Research Center, Charité, University of Berlin, Germany, Director: Univ.-Prof. Dr. Simone Spuler

Since 2010
KAP Program - Fellowship of the Charité and the Max- Delbrück- Center for Molecular Medicine. Scientific Supervisors: Prof. Dr. Simone Spuler (ECRC, Charité), Prof. Dr. Michael Bader (MDC)


Schoewel V, Marg A, Kunz S, Overkamp T, Carrazedo RS, Zacharias U, Daniel PT, Spuler S. Dysferlin-peptides reallocate mutated dysferlin thereby restoring function. PLoS One. 2012;7(11):e49603

Marg A, Schoewel V, Timmel T, Schulze A, Shah C, Daumke O, Spuler S. Sarcolemmal repair is a slow process and includes EHD2. Traffic. 2012 Sep;13(9):1286-94

Zacharias U, Purfürst B, Schöwel V, Morano I, Spuler S, Haase H. Ahnak1 abnormally localizes in muscular dystrophies and contributes to muscle vesicle release. J Muscle Res Cell Motil. 2011 Dec;32(4-5):271-80

Knoblauch, H., Schöwel, V., Rosada, A., Kress, W. and Spuler, S. Another side to statin related side effects. Ann. Intern. Med., Ann Intern Med. 2010 Apr 6;152(7):478-9.

Mikus G, Schöwel V, Drzewinska M, Rengelshausen J, Ding R, Riedel K-D, Burhenne J, Weiss J, Thomsen T, Haefeli WE: Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir. Clin Pharmacol Ther 2006, 80: 126-135.